A recent study on UK patients conducted by the researchers at the University of Pennsylvania* could have an impact on Accutane lawsuits. As most know, class actions as well as individual lawsuits have attempted to hold the manufacturer of Accutane, Hoffman-LaRoche, accountable. The Vitamin-A drug has been linked to inflammatory bowel disease, or IBD.
But wait a minute—so too are tetracycline drugs, say the U of P researchers.
So how does that impact an Accutane lawsuit?
Accutane (isotretinoin) has always been considered a last resort for problematic acne, which is the scourge of adolescents and, if left untreated, could scar the face for life.
Dermatologists will almost always start with more natural ways in which to control acne, such as diet and hygiene—or perhaps an OTC benzoyl peroxide or salicyclic acid solution.
If that doesn’t work, then they turn to tetracycline, which is an antibiotic and thought to carry minimal risk. How can you go wrong with an antibiotic, a microbial? Are they not the magic bullets of our society?
Antibiotic resistance notwithstanding, there’s now a fly in the ointment, if you will. That’s because Read the rest of this entry »